Jefferies Financial Group’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Jefferies Financial Group’s Portfolio MRNS Stock Details MRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-41,686	Closed	-$48.8K	–	1837
2024 Q2	$48.8K	Sell	41,686 -11,500	-22%	-$28.8K	﹤0.01%	1317
2024 Q1	$481K	Sell	53,186 -112,915	-68%	-$1.1M	﹤0.01%	1070
2023 Q4	$1.81M	Sell	166,101 -88,633	-35%	-$664K	0.01%	754
2023 Q3	$2.05M	Buy	254,734 +713	+0.3%	+$5.93K	0.02%	622
2023 Q2	$2.76M	Sell	254,021 -249,772	-50%	-$2.14M	0.02%	549
2023 Q1	$3.48M	Buy	503,793 +9,029	+2%	+$56.6K	0.03%	475
2022 Q4	$1.97M	Buy	+494,764	New	+$2.43M	0.01%	658

Other funds holding MRNS

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Jefferies Financial Group's MRNS Position: Q3 2024 in Review

Jefferies Financial Group sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q3 2024, closing a stake of 41,686 shares — an estimated $48.8K sold.

Jefferies Financial Group first reported a position in MRNS in Q4 2022 and held it in 7 quarters. The position peaked at $3.48M in Q1 2023. 75 funds tracked by Wall St. Rank hold MRNS as of Q3 2024.

Jefferies Financial Group reported no remaining Marinus Pharmaceuticals, Inc position as of Q3 2024 after selling out during the quarter.
Jefferies Financial Group sold 41,686 Marinus Pharmaceuticals, Inc shares in Q3 2024, an estimated $48.8K.
Jefferies Financial Group first reported a position in Marinus Pharmaceuticals, Inc in Q4 2022 and held it in 7 quarters.
Jefferies Financial Group's Marinus Pharmaceuticals, Inc position peaked at $3.48M in Q1 2023.
75 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q3 2024.

Based on Jefferies Financial Group's 13F filing for Q3 2024, filed 14 Nov 2024.